Stock Market LIVE: Nifty, Sensex Off Day's Low As ICICI Bank, Shriram Finance Shares Support

Shyam Metalics Q2 Earnings Key Highlights (Consolidated, QoQ)

• Net Profit fell 10.4% to 262 crore versus Rs 292 crore

• Revenue rose 0.9% to Rs 4,457 crore versus Rs 4,419 crore

• Ebitda fell 6.9% to Rs 539 crore versus Rs 580 crore

• Margin at 12.1% versus 13.1%

Alembic Pharmaceuticals Ltd. received the US Food and Drug Administration's approval for Dasatinib tablets. These tablets are indicated for the treatment for Leukemia in adults, the company said in the exchange filing.

TeamLease Services bought additional 10% stake in arm TSR Darashaw HR Services. It became the company's wholly-owned subsidiary post acquisition.

Divi's Laboratories Q2 Highlights (Consolidated, YoY)

• Revenue up 16.1% to Rs 2,715.00 crore versus Rs 2,338.00 crore

• Net Profit up 35% to Rs 689.00 crore versus Rs 510.00 crore

• Ebitda up  24% to Rs 888.00 crore versus Rs 716.00 crore

• Margin at 32.7% versus 30.6%

Track faster updates on Q2 earnings here.

Diversified NBFC Piramal Enterprises, which in September 2025 delisted and merged with Piramal Finance - a wholly owned subsidiary and has relisted on the stock exchanges on Friday as Piramal Finance.

The shares debuted at 12% premium at Rs 1,260 per share on the NSE in comparison to discovered price of Rs 1,124.20. However, as of 10:50 a.m. it was trading 17.59% higher at Rs 1,321.80 on the NSE and on the BSE it was trading 4.02% higher at Rs 1,321.